Garima Arora is a Cardiology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 54 publications with 299 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1808 7th Ave S
Bdb 201
Birmingham, AL 352331912
Telephone
205-394-0820Registry record last updated 1 Feb 2024.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20255 payments
- BridgeBio Pharma, Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.4%Angiotensin receptor-neprilysin inhibitor (ARNI)20.4%Entresto100%Part D≥27 patientsBeta blocker15.9%Metoprolol Succinate39%Carvedilol31%Metoprolol Tartrate30%Part D≥14 patients+ 8 more classes in this area
Metabolism & gastrointestinal
9.9%SGLT2 inhibitor9.9%Jardiance72%Farxiga28%Part D<11 patientsBlood & clotting
7.7%Factor Xa inhibitor7.7%Eliquis75%Xarelto26%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular health in pregnancy according to Life’s Essential 8 score
npj Cardiovascular Health
2026 - 26-CCC-18093-ACC PHENOCOPY PITFALL: HEREDITARY TRANSTHYRETIN AMYLOIDOSIS MIMICKING ARRHYTHMOGENIC CARDIOMYOPATHY
Journal of the American College of Cardiology
2026 - 26-A-21562-ACC LARGE-SCALE ARTIFICIAL INTELLIGENCE-BASED ANALYSIS REVEALS SYSTEMATIC DIFFERENCES IN LEFT VENTRICULAR VOLUMES BETWEEN CONTRAST-ENHANCED AND NON-CONTRAST-ENHANCED ECHOCARDIOGRAPHY
Journal of the American College of Cardiology
2026 - Differences in Statin Eligibility With the Use of Predicting Risk of Cardiovascular Disease EVENTs Versus Pooled Cohort Equations in the UK Biobank
The American Journal of Cardiology
2025 - Mavacamten Monotherapy in Real-World Patients With Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM
Circulation Genomic and Precision Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”